Trigger Point Injections in Personal Injury: Medications, Myofascial Pain, and the Pharmacy Lien

James Wong — Founder & Pharmacist, LienScripts | February 17, 2026 | 8 min read

Trigger point injections are a frontline intervention for myofascial pain after trauma. Learn which injectable and oral medications are used, which muscles are targeted, why insurers deny TPIs, and how a pharmacy lien covers the oral medication component alongside the injection series.

Myofascial Pain Syndrome After a Personal Injury

When a motor vehicle accident, workplace injury, or slip-and-fall event causes sudden trauma to the body, muscles don't just bruise — they seize. The sudden eccentric loading of a rear-end collision, the torque of a fall, or the sustained bracing that follows an acute injury can trigger myofascial pain syndrome (MPS): a chronic muscular pain condition characterized by hyperirritable spots within taut bands of skeletal muscle called trigger points.

Trigger points are not simply sore muscles. They are discrete, palpable nodules of involuntarily contracted muscle fibers that produce a predictable referral pattern when compressed or needled. A trigger point in the upper trapezius, for example, characteristically refers pain to the side of the head, the neck, and behind the eye — mimicking tension-type headache. One in the levator scapulae refers to the angle of the neck. One in the infraspinatus refers down the arm.

[!KEY] Myofascial pain syndrome is one of the most underdiagnosed consequences of motor vehicle accidents. When properly documented, a trigger point injection series provides objective evidence of persistent soft tissue pathology that supports the demand package.

In personal injury, MPS frequently coexists with disc pathology, facet joint injury, and radiculopathy. Patients often describe it as the "background ache" that never fully resolves even when nerve pain comes under some control. Trigger point injections (TPIs) are the targeted intervention for this component of post-traumatic pain.

Wet Needling vs. Dry Needling

There are two broad approaches to trigger point treatment with a needle:

Dry needling — No injectate is used. A fine filiform needle (identical to an acupuncture needle) is inserted into the trigger point to mechanically disrupt the contracted band, elicit a local twitch response, and initiate a healing cascade. Dry needling is performed by physical therapists and acupuncturists in states that permit it. It is not a pharmacy-dispensed medication, but it often occurs alongside pharmacologic treatment.

Wet needling (trigger point injection proper) — A local anesthetic, corticosteroid, or other pharmacologic agent is injected directly into the trigger point. This is typically performed by a physician (physiatrist, pain management specialist, orthopedist, or primary care physician with procedural training). The injectate mechanically disrupts the trigger point and adds pharmacologic anti-inflammatory or analgesic effect.

In personal injury, wet needling is more commonly documented in medical records and more commonly billed as a CPT-coded procedure — making it more useful for special damages documentation.

Injectable Agents Used in Trigger Point Injections

Lidocaine (0.5–1%) is the most widely used injectate for TPIs. It is short-acting (30–90 minutes of direct anesthetic effect), carries low systemic toxicity at the volumes used, and the hydrodynamic effect of the injection itself — independent of the pharmacologic action — is thought to be partly responsible for trigger point deactivation.

Bupivacaine (0.25%) is a longer-acting local anesthetic sometimes preferred for patients who respond poorly to lidocaine alone. The extended duration of anesthesia may allow the muscle to remain relaxed longer, reducing the likelihood of immediate retrigger.

Corticosteroids (methylprednisolone, triamcinolone) are sometimes added to local anesthetic, particularly when the treating physician suspects a significant inflammatory component. However, repeated steroid injection into muscle tissue carries risk of local muscle fiber atrophy, and many practitioners limit or avoid steroids in TPIs, preferring to reserve them for intra-articular or epidural use.

Saline — Some evidence suggests that isotonic saline injection is as effective as local anesthetic for trigger point deactivation, with the mechanical disruption of the needle being the primary mechanism. Saline TPIs are occasionally used in patients with local anesthetic allergies.

[!SOURCE] Cummings TM, White AR. "Needling therapies in the management of myofascial trigger point pain: a systematic review." Arch Phys Med Rehabil. 2001;82(7):986–992. PMID: 11441390. Systematic review finding that both wet and dry needling are more effective than control for myofascial trigger point pain, with no clear superiority of one injectate over another.

Common Muscles Targeted in Post-Traumatic TPI

The muscles most frequently treated with TPIs following trauma reflect the injury biomechanics of the most common personal injury events:

Upper trapezius — Nearly universal in rear-end MVA. The sudden forward-then-backward motion loads the upper trapezius eccentrically. Trigger points here refer to the lateral neck, temple, and behind the eye.

Levator scapulae — Attaches to the cervical spine and the medial scapular border. Commonly injured in rear-end collisions; refers pain to the angle of the neck and posterior shoulder.

Sternocleidomastoid (SCM) — Often overlooked. The SCM is injured in whiplash events that involve rotation as well as flexion-extension. SCM trigger points refer to the forehead, eye region, and ear — commonly misidentified as headache or inner ear pathology.

Paraspinal muscles (cervical and lumbar) — The erector spinae group and multifidus are routinely involved in both cervical and lumbar injury patterns. Lumbar paraspinal TPIs are among the most common in slip-and-fall and workplace injury cases.

Piriformis — Hip and buttock pain after falls or seat-belt injuries. Piriformis trigger points refer down the posterior thigh and can mimic sciatica.

Quadratus lumborum (QL) — A deep lumbar muscle that is a primary driver of low back pain after lifting injuries and MVA. QL trigger points refer to the sacroiliac region and lateral hip.

How TPIs Fit Alongside Oral Medications

Trigger point injections are not a replacement for oral pharmacotherapy — they are complementary. The injection addresses the focal contracted band directly; oral medications manage the surrounding inflammatory and central sensitization processes that sustain myofascial pain.

[!KEY] Between injection appointments, the oral medication component is where the pharmacy lien provides direct, measurable value. Every filled prescription between TPI visits represents documented, out-of-pocket equivalent treatment cost recoverable at settlement.

Muscle relaxants are the cornerstone oral medication alongside a TPI series. Cyclobenzaprine, tizanidine, methocarbamol, and baclofen all reduce the sustained muscle hypertonicity that perpetuates trigger point activity. Patients typically take muscle relaxants at bedtime (given sedation) or in lower daytime doses.

NSAIDs (meloxicam, naproxen, diclofenac, ibuprofen) address the local inflammatory component. They are often prescribed around-the-clock on a scheduled basis rather than as-needed, to maintain consistent anti-inflammatory levels between injection visits.

Topical agents — Diclofenac gel, lidocaine patches, and compounded topical muscle relaxant/anti-inflammatory formulations are frequently applied directly to the skin overlying the affected muscle groups between injections. These reduce local pain without adding systemic medication burden.

Low-dose tricyclics or SNRIs — When myofascial pain becomes chronic, physicians sometimes add low-dose amitriptyline, nortriptyline, or duloxetine to address central sensitization and the often co-occurring sleep disruption that perpetuates pain.

A pharmacy lien program covers all of these oral and topical agents on lien — meaning patients fill prescriptions at no out-of-pocket cost, with the lien balance due from the settlement.

Why Insurers Deny TPIs

Health insurers apply coverage criteria that frequently exclude TPIs or impose significant prior authorization barriers:

• Many plans require documented failure of 4–8 weeks of physical therapy before approving TPIs.
• Some plans classify TPIs as "experimental" for certain diagnoses despite decades of clinical use.
• Auto insurance MedPay and PIP benefits may not include injectable procedures at all.
• Coverage may be exhausted before the patient completes a full injection series.

For personal injury patients without active health insurance, or whose insurer has denied, the treating physician may work on a medical lien. The pharmacy lien covers the concurrent oral and topical medications.

Documentation for the Demand Package

A TPI series documented correctly creates a compelling special damages narrative:

1. Primary care or orthopedic referral notes — confirming the clinical diagnosis of myofascial pain syndrome with palpable trigger points, their locations, and referral patterns documented.
2. Procedure notes for each TPI session — date, muscles injected, injectate used, volume, patient tolerance, immediate response.
3. Follow-up visit notes — documenting response duration, persistence of trigger points, decision to repeat vs. transition to other treatment.
4. Physical therapy records — if PT ran concurrently, noting tender point examination findings that corroborate the physician's findings.
5. Pharmacy lien medication summary — all oral and topical prescriptions filled on lien, organized by date and prescribing provider.

When multiple muscle groups require repeated treatment, a TPI series across a PI case duration can represent substantial billed medical value. Combined with the pharmacy lien medication record, this total treatment cost becomes the special damages foundation.

Coordinating the Pharmacy Lien Alongside TPI Care

LienScripts works directly with personal injury attorneys and treating physicians to ensure the oral medication component is covered from the first prescription. When an attorney refers a patient to a pain management or physiatry practice for TPI treatment, the pharmacy lien can:

• Fill the initial muscle relaxant and NSAID prescriptions before the first injection appointment.
• Continue filling medications between TPI sessions when muscle pain partially returns.
• Dispense topical formulations that allow patients to manage muscle pain at home between visits.
• Provide the attorney a complete, date-ordered medication summary organized by prescribing provider for demand package assembly.

This coordination eliminates the gap in treatment that occurs when patients cannot afford prescriptions between injection appointments — and ensures every treatment dollar is captured as a documented lien balance.

Related Resources

• What Is a Pharmacy Lien? A Plain-Language Guide
• Cyclobenzaprine vs. Tizanidine for Muscle Relaxation in Personal Injury
• Soft Tissue Injury Medications and the Pharmacy Lien
• Pain Management After a Car Accident: What to Expect